<?xml version="1.0" encoding="UTF-8"?>
			<!DOCTYPE ipharmsciencia.edwiserinternational.com [
<!ELEMENT channel (title,link,description,language,managingEditor,webMaster,copyright,image,item,item,item,item)>
<!ELEMENT title (#PCDATA)>
<!ELEMENT link (#PCDATA)>
<!ELEMENT language (#PCDATA)>
<!ELEMENT managingEditor (#PCDATA)>
<!ELEMENT webMaster (#PCDATA)>
<!ELEMENT copyright (#PCDATA)>

<!ELEMENT image (title,link,url,width,height)>
<!ELEMENT url (#PCDATA)>
<!ELEMENT width (#PCDATA)>
<!ELEMENT height (#PCDATA)>

<!ELEMENT item (title,pubDate,link,author,comments,category,description)>
<!ELEMENT pubDate (#PCDATA)>
<!ELEMENT author (#PCDATA)>
<!ELEMENT comments (#PCDATA)>
<!ELEMENT category (#PCDATA)>
<!ELEMENT description (#PCDATA)>

]>
		<channel>
<title>Internationale-Pharmaceutica-Sciencia-ISSUE VOLUME Volume 11 ISSUE Issue 1</title>
<link>http://ipharmsciencia.edwiserinternational.com/rss-feed.php</link>
<description>
Internationale-Pharmaceutica-Sciencia: VOLUME Volume 11 ISSUE Issue 1,  2020
</description>
<language>en-us</language>
<managingEditor>editor@edwiserinternational.com</managingEditor>
<webMaster>editor@edwiserinternational.com</webMaster>
<copyright>editor@edwiserinternational.com</copyright>
<image>
<title>Internationale-Pharmaceutica-Sciencia-ISSUE VOLUME Volume 11 ISSUE Issue 1</title>
<link>http://ipharmsciencia.edwiserinternational.com/rss-feed.php</link>
<url>http://ipharmsciencia.edwiserinternational.com/img/logo1.png</url>
<width>360</width>
<height>109</height>
</image><item>
		<title>Chemical-Composition-and-Pharmacology-of-a-Medicinal-Herb-Swertia-Chirata</title>
		<pubDate>16-Nov-2020</pubDate>
<link>http://ipharmsciencia.edwiserinternational.com/admin/uploads/aChg39.pdf</link>
		<author>Kaloo-MA-and-Bhat-BA</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Swertia chirata is used as folkore medicine in the treatment of mental disorders ulcers, liver disorder, febrifuge, anthelmintic, antimalarial, skin diseases etc. Phytochemical screening of the extract prepared by soxhlet apparatus confirmed the presence of broader range of bioactive chemical constituents like steroids, tannins, phenolics, saponins, alkaloids, flavonoids, and glycosides. So, the present review based on whole literature available about the medicinal plant was designed to describe the whole work which is carried out about the Swertia chirata. We have also summarized the possibilities of carrying out of unexplored work on the plant in the future.]]>}</description>
		</item><item>
		<title>Different-Analytical-Procedures-for-the-Estimation-of-Serratiopeptidase</title>
		<pubDate>16-Nov-2020</pubDate>
<link>http://ipharmsciencia.edwiserinternational.com/admin/uploads/BnWFjK.pdf</link>
		<author>Vikrant-Verma</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[In this review dierent analytical technique used for the analysis of serratiopeptidase, a proteolytic enzyme, which has recently gained importance as an anti-inammatory agent are discussed. Every work has been done to unite all the appropriate references to the degree possible. The review put emphasis on the merits and demerits of the given analytical procedures, which will assist to give insights into the methods used for estimation of serratiopeptidase as such, from clinical isolates and from its dosage forms. The review article gives the fundamental as well as highly developed techniques executed for the estimation of serratiopeptidase. The techniques given here have been established to be useful for determination of serratiopeptidase and may nd purpose in analyzing other related proteases.]]>}</description>
		</item><item>
		<title>In-vitro-Characterization-of-Floating-Granules-of-Furosemide</title>
		<pubDate>16-Nov-2020</pubDate>
<link>http://ipharmsciencia.edwiserinternational.com/admin/uploads/M5aRjT.pdf</link>
		<author>-Islam-M-Dharwal-M-and-Verma-NK</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[The objective of the study is to formulate and optimize Furosemide based controlled release system for increasing the bioavailability by influencing the residence time in the stomach while remaining detached from the mucosa. This was achieved by successful preparation of floating granules by exploiting melt granulation technique. The formulations F1 to F6 were developed and evaluated for dependent variable (in vitro floating ability) and formulations F4 to F6 were selected as preliminary optimized formulations. The preliminary optimized formulation F4 to F6 were evaluated for micromeritic properties, drug content and percentage yield, in-vitro drug release, percentage in-vitro floating ability. The formulation F4 was selected as optimized formulation exhibiting good floating ability and zero order drug release (85.95 %) at the end of 8 hours. Aging effect on storage was evaluated using In-vitro drug release studies. The In-vitro drug release study of the aged sample showed increase in release behavior, which can be attributed to the phase transformation of Gelucire. In conclusion, hydrophobic lipid, Gelucire 43/01 can be considered as an effective carrier for designing of a multi-unit floating drug delivery system of Furosemide.]]>}</description>
		</item><item>
		<title>A-Concise-Review-on-Methods-of-Solubility-Enhancement</title>
		<pubDate>16-Nov-2020</pubDate>
<link>http://ipharmsciencia.edwiserinternational.com/admin/uploads/Cb74TH.pdf</link>
		<author>Godase-CB-Babar-AL-and-Gopal-AB</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Solubility is not to be confused with the ability to dissolve or liquefy a substance, since this process may occur not only because of dissolution but also because of a chemical reaction. Low aqueous solubility is the major problem encountered with formulation development of new chemical entities as well as for the generic development. More than 40% of new chemical entities developed in pharmaceutical industry are lipophillic and fail to reach the market due to their poor water solubility. The solubility behavior of drug is the major challenge for formulation scientist. The present review is devoted to increase the solubility of poorly water-soluble drugs.]]>}</description>
		</item></channel>